Výsledky vyhledávání - "Víctor, Amado"

Akademický článek

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing

Autor: Juan L. López‐Cánovas, Natalia Hermán‐Sánchez, Maria Trinidad Moreno‐Montilla, Mercedes del Rio‐Moreno, Emilia Alors‐Perez, Marina E. Sánchez‐Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de laMata, Justo P. Castaño, Manuel Rodriguez‐Perálvarez, Raúl M. Luque, Manuel D. Gahete

Publikováno v: Clinical and Translational Medicine, Vol 12, Iss 11, Pp n/a-n/a (2022)

Abstract Introduction Altered splicing landscape is an emerging cancer hallmark; however, the dysregulation and implication of the cellular machinery controlling this process (spliceosome components and splicing factors) in hepatocellular carcinoma (

Externí odkaz: https://doaj.org/article/44c65a5a43f5401cba4cff96e19ce370

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing

Autor: Juan L. López-Cánovas, Natalia Hermán-Sánchez, Mercedes del Rio-Moreno, Antonio C. Fuentes-Fayos, Araceli Lara-López, Marina E. Sánchez-Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de la Mata, Justo P. Castaño, Manuel Rodriguez-Perálvarez, Raúl M. Luque, Manuel D. Gahete

Publikováno v: Experimental & Molecular Medicine. 55:132-142

Hepatocellular carcinoma (HCC) pathogenesis is associated with alterations in splicing machinery components (spliceosome and splicing factors) and aberrant expression of oncogenic splice variants. We aimed to analyze the expression and potential role

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::587a69fb88aa6a3e004817e5b25b6f3a
https://doi.org/10.1038/s12276-022-00917-7

Zobrazit plný text záznamu

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing

Autor: Juan L, López-Cánovas, Natalia, Hermán-Sánchez, Mercedes, Del Rio-Moreno, Antonio C, Fuentes-Fayos, Araceli, Lara-López, Marina E, Sánchez-Frias, Víctor, Amado, Rubén, Ciria, Javier, Briceño, Manuel, de la Mata, Justo P, Castaño, Manuel, Rodriguez-Perálvarez, Raúl M, Luque, Manuel D, Gahete

Publikováno v: Experimentalmolecular medicine.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::be58e4f087134a3e93f270cb8f37f285
https://pubmed.ncbi.nlm.nih.gov/36609600

Zobrazit plný text záznamu

Area Under Trough Concentrations of Tacrolimus as a Predictor of Progressive Renal Impairment After Liver Transplantation

Autor: Rachel H. Westbrook, José Luis Montero, María D Aumente, David Patch, Emmanuel Tsochatzis, Marta Guerrero, Douglas Thorburn, Laura De Luca, James O'Beirne, Manuel de la Mata, Beatriz Gros, Rocío Fernández, Manuel Rodríguez-Perálvarez, Víctor Amado, Patricia Aguilar, Javier Briceño

Publikováno v: Transplantation. 103:2539-2548

BACKGROUND Tacrolimus minimization is usually restricted to patients with pretransplant renal impairment, and this strategy could result into worse renal outcomes after liver transplantation (LT). METHODS A consecutive cohort of 455 LT patients recei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be3feb3b6e20bfe3433cef0b84bd67b0
https://doi.org/10.1097/tp.0000000000002760

Zobrazit plný text záznamu

Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation

Autor: Manuel Rodríguez-Perálvarez, Javier Zamora, Gema Garcia-Jurado, Marina E. Sánchez-Frías, María Lola Espejo-Cruz, Manuel de la Mata, Ruben Ciria, Clara I. Linares, Víctor Amado, Sandra González-Rubio, Gustavo Ferrín, Rafael Alejandre, José Luis Montero

Publikováno v: Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2476, p 2476 (2021)

Background: In patients with hepatocellular carcinoma (HCC), a complete clearance of circulating tumor cells (CTCs) early after liver transplantation (LT) or surgical resection (LR) could prevent tumor recurrence. Methods: prospective pilot study inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b96d4c652322ebc873cfe0f8338ee0
http://europepmc.org/articles/PMC8160727

Zobrazit plný text záznamu

Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal

Autor: María Lola Espejo-Cruz, Javier Zamora-Olaya, Sandra González-Rubio, Víctor Amado-Torres, Marina E. Sánchez-Frías, Rafael Alejandre, Manuel de la Mata, Ruben Ciria, Manuel Rodríguez-Perálvarez, Gustavo Ferrín

Publikováno v: International Journal of Molecular Sciences 22(23), 13073 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 13073, p 13073 (2021)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
International Journal of Molecular Sciences

Hepatocellular carcinoma (HCC) is the fifth most common neoplasm and a major cause of cancer-related death worldwide. There is no ideal biomarker allowing early diagnosis of HCC and tumor surveillance in patients receiving therapy. Liquid biopsy, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49311c131f75983da4ea3f5b3b6a7ddd
https://hdl.handle.net/10396/22198

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání